Alterity Therapeutics (ATHE) Revenue (2016 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Revenue of $1.3 million for Q4 2019, down 26.34% year-over-year from $1.7 million in Q4 2018, and down 26.34% quarter-over-quarter from $1.7 million in Q4 2018.
Alterity Therapeutics (ATHE) Revenue (2016 - 2025) Analysis & Trends
Alterity Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $1.3 million for Q4 2019.
- In Q4 2019, Revenue fell 26.34% year-over-year to $1.3 million; the TTM figure through Dec 2019 stood at $4.2 million (up 32.83% YoY), while the FY2024 annual figure was $47357.5, changed N/A from the prior year.
- Revenue for Q4 2019 stood at $1.3 million, down from $1.7 million in the prior quarter.
- The five-year high for Revenue was $1.7 million in Q4 2018, with the low at -$87534.3 in Q4 2017.
- The 4-year median for Revenue is $1.3 million (2016), against an average of $1.1 million.
- The sharpest annual moves came in 2017 and 2018: Revenue sank 106.67% in 2017, then surged 2065.6% in 2018.
- Alterity Therapeutics' Revenue stood at $1.3 million in 2016, then slumped by 106.67% to -$87534.3 in 2017, then jumped by 2065.6% to $1.7 million in 2018, then retreated by 26.34% to $1.3 million in 2019.
- Business Quant data shows ATHE's Revenue at $1.3 million in Q4 2019, $1.7 million in Q4 2018, and -$87534.3 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Alterity Therapeutics | 50.14 Mn | 17.84 Mn | - | 5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.21 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Dec 31, 2023 | 4.14 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 4.93 Mn |
| Dec 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 1.72 Mn |
| Dec 31, 2017 | -87,534.28 |
| Dec 31, 2016 | 1.31 Mn |